Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 150,609 | 155,974 | 391 | 6,512 | N/A |
| Marketable Securities | 55,115 | N/A | N/A | N/A | N/A |
| TOTAL | $207,751 | $157,956 | $954 | $6,866 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,754 | 240 | 327 | 328 | N/A |
| Investments And Advances | 8,658 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,174 | 30 | 30 | 30 | 0 |
| TOTAL | $12,586 | $270 | $357 | $358 | $N/A |
| Total Assets | $220,337 | $158,226 | $1,311 | $7,224 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,288 | 1,740 | 1,076 | 1,142 | 0 |
| Accrued Expenses | 5,825 | 1,168 | 764 | 759 | N/A |
| Other current liabilities | 62 | 305 | 24 | 16 | N/A |
| TOTAL | $12,301 | $3,292 | $1,930 | $2,117 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 126 | 79 | 66 | 200 | N/A |
| TOTAL | $1,242 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $13,543 | $3,292 | $1,930 | $2,117 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,380 | 1,985 | N/A | N/A | N/A |
| Common Shares | 3 | 3 | N/A | N/A | N/A |
| Retained earnings | -138,346 | -62,569 | -28,622 | -12,734 | N/A |
| Other shareholders' equity | -29 | 0 | 18,278 | 10,778 | 0 |
| TOTAL | $206,794 | $154,934 | $-619 | $5,107 | $N/A |
| Total Liabilities And Equity | $220,337 | $158,226 | $1,311 | $7,224 | $0 |